Open access
75
Views
1
CrossRef citations to date
0
Altmetric
Review
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
Jorge Correale1 Department of Neurology, Raúl Carrea Institute for Neurological Research, Foundation for the Fight against Infant Neurological Illnesses (FLENI), Buenos Aires, ArgentinaCorrespondence[email protected]
, Erwin Chiquete2 Department of Neurology and Psychiatry, Salvador Zubirán National Institute of Medical Sciences and Nutrition, Mexico City, Mexico
, Alexey Boyko3 Clinical and Research Center “MS and Other Demyelinating Diseases” at the Neuroclinical Hospital, Department of Neurology, Neurosurgery and Medical Genetics of the Pirogov Russian National Research Medical University, Moscow, Russia
, Roy G Beran4 South Western Clinical School, University of New South Wales, Liverpool;5 Department of Neurology, Liverpool Hospital, Sydney, NSW;6 School of Medicine, Griffith University, Southport, QLD, Australia
, Jorge Barahona Strauch7 Department of Neurology, Clínica Alemana de Santiago;8 School of Medicine, Universidad del Desarrollo, Santiago, Chile
, Snezana Milojevic9 Novartis Pharma AG, Basel, Switzerland
& Nadina Frider10 Novartis Latin America and Canada Region, Buenos Aires, Argentina
show all
Pages 2109-2117
|
Published online: 30 Jun 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.